TrialsgrambetaRCTs are beautiful

MIST-2

2011

Intrapleural tPA + DNase in Pleural Infection

In 210 patients with pleural infection, intrapleural tPA + DNase twice daily for 3 days reduced pleural opacity and surgical referral compared with placebo or single-agent therapy.

Result

Primary endpoint: Pleural opacity on CXR at day 7

-29.5% (combo) vs -17.2% (placebo; p=0.005); surgical referral 4% vs 16% (p=0.03); shorter LOS. Monotherapy ineffective.

Original publication
Subtopic
Pleural infection
Design
2×2 factorial RCT
Relevance
Important: one of several pillars.
Source
Rahman NM, et al. N Engl J Med. 2011;365(6):518-526.doi 10.1056/NEJMoa1012740

Discussion & critique

Established combination intrapleural tPA/DNase for pleural infection failing chest-tube drainage.

Discussed in podcasts